Skip to content
Richard Peek
Home
Contact Me
Publications
Richard Peek
←
TVB-2640 (FASN inhibitor) for the treatment of nonalcoholic steatohepatitis: FASCINATE-1, a randomized, placebo-controlled Ph2a trial
Preparing for the NASH Epidemic: A Call to Action
→
Elsewhere in The AGA Journals
Posted on
July 24, 2021
by
Gastroenterology
This entry was posted in
News
. Bookmark the
permalink
.
←
TVB-2640 (FASN inhibitor) for the treatment of nonalcoholic steatohepatitis: FASCINATE-1, a randomized, placebo-controlled Ph2a trial
Preparing for the NASH Epidemic: A Call to Action
→
Links
Gastroenterology
MyVUMC
July 2021
S
M
T
W
T
F
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
Aug »
Other websites
Etiological Studies of Gastric Carcinoma
H. pylori and Gastric Cancer
